[Trial of Tandearil in prevention of cutaneous and mucosal complications in patients with otorhinolaryngeal neoplasms treated by irradiation].
D004428:Ear Neoplasms / Q000532:radiotherapy; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D009669:Nose Neoplasms / Q000532:radiotherapy; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011832:Radiation Injuries / Q000517:prevention & control*; D011855:Radiodermatitis / Q000517:prevention & control
D010113:Oxyphenbutazone
Essai de prevention par le Tanderil des incidents cutanes et muqueux survenant chez les malades porteurs d'affections neoplasiques ORL traites par irradiation